Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2003
05/01/2003US20030082578 In vitro amplification of nucleic acid molecules via circular replicons
05/01/2003US20030082577 Detection of bacterial infections; obtain sample, extract nucleotide sequences, incubate with primers, amplify sequence, incubate with probe, monitor mass spectrum, compare to control, evaluate for legionella infection
05/01/2003US20030082576 Detection of polymorphic nucleotide sequences; obtain nucleotide sequences, incubate with solid substrate containing primers, a mplify sequences, incubate with probe, detect signal, analyze polymorphic sequences
05/01/2003US20030082575 Translation system for use in the generation of protein containing adjusted amino acid sequences
05/01/2003US20030082573 Cell cycle protein
05/01/2003US20030082572 Methods and compositions for nucleotide analysis
05/01/2003US20030082571 Linear nucleic acid and sequence therefor
05/01/2003US20030082570 High-throughput transcriptome and functional validation analysis
05/01/2003US20030082569 Histoplasma capsulatum catalase sequences and their use in the detection of Histoplasma capsulatum and Histoplasmosis
05/01/2003US20030082568 Detecting preferential agent in sample; prepare reporter beads, incubate with sample, isolate bound complex
05/01/2003US20030082567 Mineral hot start PCR method
05/01/2003US20030082566 Method for determining allele frequencies
05/01/2003US20030082565 Preparing kit for amplification of nucleotide sequences; obtain container, fill with solid support, cover, seal recover package
05/01/2003US20030082564 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
05/01/2003US20030082563 Detection of bacillus anthracis
05/01/2003US20030082562 Sequencing preferential nucleic acids; provide nucleotide sequences, separate using liquid chromatography, detect preferential sequences, determine polarity sequences
05/01/2003US20030082558 Preparation of labelled nucleotide sequences; obtain nucleotide sequences, denature, incubate with primer, polymerase and and labelled amplification mixture, amplify, recover labelled nucleotide sequences
05/01/2003US20030082557 Preparing preferential nucleotide sequences; obtain nucleic acid, denature, incubate with primer, amplify, denature and hybridize with wildtype nucleotide sequences, recover heteroduplex nucleotide sequences
05/01/2003US20030082556 Binary encoded sequence tags
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082553 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders
05/01/2003US20030082551 High-throughput gene cloning and phenotypic screening
05/01/2003US20030082550 Nucleotide sequences coding polypeptide for use in the treatment of fever, arthritis, alzheimer's, epilepsy, inflammation and bone disorders
05/01/2003US20030082549 Method for determining alleles
05/01/2003US20030082548 Brain selective transmembrane receptor gene
05/01/2003US20030082547 Non-fluorescent quencher compounds and biomolecular assays
05/01/2003US20030082546 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders and cancer
05/01/2003US20030082545 Quantitative analysis of cancer-associated mutations; genetic engineering
05/01/2003US20030082543 Method of target enrichment and amplification
05/01/2003US20030082542 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082541 Nucleotide sequences coding polypeptide for use in the treatment of skin disorders and cancer
05/01/2003US20030082540 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082539 Detecting biological warfare agent; obtain nucleotide sequences, incubate with primers, amplify, determine mass of amplification product, compare to control, classify amplification product
05/01/2003US20030082538 Analysis of data from liquid chromatographic separation of DNA
05/01/2003US20030082537 Determining haplotype of alleles; obtain nucleotide sequence samples, incubate wth primer, amplify, recover amplification product, compare to control, detect adjustment in nucleotide sequence of amplification products
05/01/2003US20030082535 Method, compositions and kit for detection of microorganisms and bi-directional sequencing of nucleic acid polymers
05/01/2003US20030082534 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of brain and psychological disorders
05/01/2003US20030082533 Intelectin
05/01/2003US20030082531 Detecting preferential nucleotide sequences in sample; obtain sample of nucleotide sequences, incubate with primer, detect hybridization, extending the primer, detect and analyze extension product
05/01/2003US20030082530 Reagent Kit for Determining Specific Nucleotide Variations
05/01/2003US20030082529 Kit for use in the detect of viral infection in humans
05/01/2003US20030082528 Detecting preferential microorganisms in animal; prepare analytical apparatus, position in environment where animal will make contact with apparatus, recover apparatus, screen for presenc odf bacteria
05/01/2003US20030082526 Diagnosis and treatment of cancer
05/01/2003US20030082523 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
05/01/2003US20030082520 Procedure for quantitative determination of viral particles having a cholesterol-containing envelope
05/01/2003US20030082519 Cellular kinases involved in Cytomegalovirus infection and their inhibition
05/01/2003US20030082518 Genetic engineering; quantitative analysis; medical diagnosis
05/01/2003US20030082516 Rapid detection of replicating cells
05/01/2003US20030082514 Detecting active biopolymers in sample; provide vectors, transduce cells, recover transduced cells, propagate cells, detect adjusted phenotypes, sequence nucleotide acids in trangenic cells, isolated ligand for biopolymers
05/01/2003US20030082513 Detecting cell to cell activity in sample; obtain cells, polarize, incubate with fluorescent dye, determine membrane potential of cells, monitor adjustment in membrane potenial between cells
05/01/2003US20030082512 Screening therapeutic agent for treating glomerulonephritis; obtain granulocytes, generate gene expression profile, expose to therapeutic compound, monitor adjustments in profile, adjustment in profile indicates therapeutic agent
05/01/2003US20030082238 Matrices for drug delivery and methods for making and using the same
05/01/2003US20030082237 Binding to block polymer, polyelectrolytes; drug delivery, magnetism, optics, electronics
05/01/2003US20030082210 Sequence determination; calibration
05/01/2003US20030082202 Tryparedoxin, expression plasmid, process of production, method of use, test kit, and pharmaceutical composition
05/01/2003US20030082176 Therapy for metabolism disorders
05/01/2003US20030082167 Extraction from cell membrane; anticancer agents, antiinflammatroy agents, autoimmune disease; sustained release
05/01/2003US20030082158 Production of transduced hematopoietic progenitor cells
05/01/2003US20030082155 Antidiabetic agents; cell differentiation of stem cells
05/01/2003US20030082153 Stem cells that transform to beating cardiomyocytes
05/01/2003US20030082142 Replication incompetent herpes viruses for use in gene therapy
05/01/2003US20030082140 Increasing the amount of the cell differentiation associated protein, MDA-7 and decreasing RAS gene activity by administering a viral vector comprising an MDA-7 gene and an antisense ras oligonucleotide; treating pancreatic cancer
05/01/2003US20030082135 Pathway of RANTES-mediated chemokine synthesis in astrocytes and methods of use therefor
05/01/2003US20030082074 Visual blood glucose test strip
05/01/2003US20030081209 Apparatus and method for measuring micro area in specimen
05/01/2003US20030080314 Method and device for taking measurements of cells which are contained in a liquid environment
05/01/2003US20030080160 Liquid droplet ejecting method and a liquid droplet ejection apparatus
05/01/2003CA2842429A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2675409A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2470197A1 Mycobacterial genes down-regulated during latency
05/01/2003CA2465288A1 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
05/01/2003CA2465274A1 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
05/01/2003CA2465261A1 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
05/01/2003CA2464700A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2464608A1 Method for williams-beuren syndrome diagnosis
05/01/2003CA2464464A1 Transfection kinetics and structural promoters
05/01/2003CA2464462A1 Nucleic acid isolation method and apparatus for performing same
05/01/2003CA2464396A1 Method for screening agent acting on cell wall
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2464088A1 Stem cells that transform to beating cardiomyocytes
05/01/2003CA2463946A1 Assay for phospholipid transfer protein (pltp) activity
05/01/2003CA2463746A1 Methods and compositions to evaluate antibody treatment response
05/01/2003CA2463467A1 Cell separation matrix
05/01/2003CA2463420A1 Methods for detecting genetic haplotypes by interaction with probes
05/01/2003CA2462712A1 Pig mast cell cultures and uses thereof
05/01/2003CA2462581A1 Diagnostic method
05/01/2003CA2462238A1 Specimen vial sealing apparatus and method
05/01/2003CA2461665A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2461543A1 Sperm factor sequences
05/01/2003CA2460944A1 Lrrcaps as modifiers of the p53 pathway and methods of use
05/01/2003CA2458802A1 Rapid and sensitive detection of molecules
05/01/2003CA2457545A1 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor
05/01/2003CA2402588A1 Taxonomic identification of pathogenic microorganisms and their toxic proteins
04/2003
04/30/2003CN1415020A Method of detecting variation and/or polymorphism
04/30/2003CN1415017A UDP-glucose: aglycon-glacosyltransferase
04/30/2003CN1415016A Trichoderma reesei木聚糖酶 Trichoderma reesei xylanase
04/30/2003CN1414951A Drug discharge pump inhibitors
04/30/2003CN1414871A Placental human necerokinin B precursor
1 ... 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 ... 3003